(Q44780698)

English

A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease

scientific article published in May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease (English)

1 reference

Europe PubMed Central

6 December 2017

author name string

K B Miller

1

1 reference

Europe PubMed Central

6 December 2017

T F Roberts

2

1 reference

Europe PubMed Central

6 December 2017

G Chan

3

1 reference

Europe PubMed Central

6 December 2017

D P Schenkein

4

1 reference

Europe PubMed Central

6 December 2017

D Lawrence

5

1 reference

Europe PubMed Central

6 December 2017

K Sprague

6

1 reference

Europe PubMed Central

6 December 2017

G Gorgun

7

1 reference

Europe PubMed Central

6 December 2017

V Relias

8

1 reference

Europe PubMed Central

6 December 2017

H Grodman

9

1 reference

Europe PubMed Central

6 December 2017

A Mahajan

10

1 reference

Europe PubMed Central

6 December 2017

F M Foss

11

1 reference

Europe PubMed Central

6 December 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

6 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

6 December 2017

33

1 reference

Europe PubMed Central

6 December 2017

9

1 reference

Europe PubMed Central

6 December 2017

881-889

1 reference

Europe PubMed Central

6 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704454

0 references

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Pathophysiology and treatment of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Understanding the alloresponse: new approaches to graft-versus-host disease prevention.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Extracorporeal photochemotherapy in the treatment of severe graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Immunosuppressive effects of pentostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

21 January 2018

Outcome after allogeneic bone marrow transplant for leukemia in older adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic transplantation after failure of first autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical large animal models for hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Engraftment with peripheral blood stem cells collected by large-volume leukapheresis for patients with lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Photoinactivation of T-cell function with psoralen and UVA radiation suppresses the induction of experimental murine graft-versus-host disease across major histocompatibility barriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704454

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704454

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44780698&oldid=2041073157"